All Stories

  1. Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study

    Article • Journal of Neuropsychiatry, January 2018, American Psychiatric Association

    Dr Christopher D Verrico

  2. Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users

    Article • Neuropharmacology, October 2014, Elsevier

    Dr Christopher D Verrico

  3. The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders

    Article • Psychiatry Research, October 2014, Elsevier

    Dr Christopher D Verrico

  4. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study

    Article • Drug and Alcohol Dependence, August 2014, Elsevier

    Dr Christopher D Verrico

  5. Fatty acid amide hydrolase gene variant influences acute responses to cocaine

    Article • Drug and Alcohol Dependence, July 2014, Elsevier

    Dr Christopher D Verrico

  6. State versus trait: Evaluating the stability of neurocognitive functioning over time in cocaine-dependent participants

    Article • Drug and Alcohol Dependence, July 2014, Elsevier

    Dr Christopher D Verrico

  7. Repeated Δ9-Tetrahydrocannabinol Exposure in Adolescent Monkeys: Persistent Effects Selective for Spatial Working Memory

    Article • American Journal of Psychiatry, April 2014, American Psychiatric Association

    Dr Christopher D Verrico

  8. Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, April 2014, Elsevier

    Dr Christopher D Verrico

  9. Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers

    Article • The International Journal of Neuropsychopharmacology, January 2014, Oxford University Press (OUP)

    Dr Christopher D Verrico

  10. Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

    Article • Expert Opinion on Investigational Drugs, September 2013, Informa Healthcare

    Dr Christopher D Verrico

  11. Endocannabinoid metabolism in the prefrontal cortex in schizophrenia

    Article • Schizophrenia Research, June 2013, Elsevier

    Dr Christopher D Verrico

  12. Faculty Opinions recommendation of Cannabis withdrawal in chronic cannabis users with schizophrenia.

    Article • December 2012, F1000Research

    Dr Christopher D Verrico

  13. Delay- and Dose-Dependent Effects of Δ9-Tetrahydrocannabinol Administration on Spatial and Object Working Memory Tasks in Adolescent Rhesus Monkeys

    Article • Neuropsychopharmacology, January 2012, Springer Science + Business Media

    Dr Christopher D Verrico

  14. Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys

    Article • Brain Research, March 2011, Elsevier

    Dr Christopher D Verrico

  15. Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder

    Article • Neuropsychopharmacology, June 2010, Springer Science + Business Media

    Dr Christopher D Verrico

  16. MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor

    Article • Journal of Psychopharmacology, January 2008, SAGE Publications

    Dr Christopher D Verrico

  17. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment

    Article • Psychopharmacology, October 2005, Springer Science + Business Media

    Dr Christopher D Verrico

  18. Highlights from the Literature

    Article • Physiology, August 2004, American Physiological Society

    Dr Christopher D Verrico

  19. Repeated, Intermittent Δ9-Tetrahydrocannabinol Administration to Rats Impairs Acquisition and Performance of a Test of Visuospatial Divided Attention

    Article • Neuropsychopharmacology, August 2003, Springer Science + Business Media

    Dr Christopher D Verrico

  20. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats

    Article • Synapse, April 2003, Wiley

    Dr Christopher D Verrico

  21. Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat

    Article • Synapse, March 2003, Wiley

    Dr Christopher D Verrico

  22. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine

    Article • Brain Research, December 2002, Elsevier

    Dr Christopher D Verrico

  23. Cannabinoid effects on neurocognition: Implications for psychosis

    Article • European Neuropsychopharmacology, October 2002, Elsevier

    Dr Christopher D Verrico

  24. Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects

    Article • Biological Psychiatry, February 2001, Elsevier

    Dr Christopher D Verrico

  25. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats

    Article • Neuroscience Letters, December 1998, Elsevier

    Dr Christopher D Verrico

  26. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress

    Article • Brain Research, August 1998, Elsevier

    Dr Christopher D Verrico

  27. Repeated exposure to Δ9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat

    Article • Neuroscience Letters, April 1998, Elsevier

    Dr Christopher D Verrico

  28. Diet-induced changes in serum cholesterol concentrations do not alter tryptophan hydroxylation rate or serotonin concentrations in gerbil brain

    Article • Life Sciences, March 1996, Elsevier

    Dr Christopher D Verrico